Navigation Links
Polar Named Official Heart Rate Technology Supplier of U.S. Soccer Federation
Date:2/29/2012

LAKE SUCCESS, N.Y., Feb. 29, 2012 /PRNewswire/ -- Polar, the leader in heart rate monitoring and fitness assessment technologies, announced today that it will be the "Official Heart Rate Technology Supplier" for U.S. Soccer through 2013. 

As U.S. Soccer prepares for a year packed with major national and international events, including the London 2012 Olympic and Paralympic Games, heart rate technology devices from Polar will be used to help these nine National Teams gain a competitive training edge:

  • Men's National Team
  • Women's National Team
  • Men's Under-23 Team
  • Women's Under-23 Team
  • Men's Under-20 Team
  • Women's Under-20 Team
  • Men's Under-17 Team
  • Women's Under-17 Team
  • U.S. National Paralympics Soccer Team
  • The teams will mainly use the Polar Team2 Pro set, which helps coaches and trainers gain unique insight into each athlete's fitness level. Using heart rate-based training sessions can monitor athletes' intensity at all times, optimize their fitness levels, and help prevent overtraining and injuries. By taking into consideration each individual's training load (the cumulative effect of recent training sessions), coaches and trainers can develop personalized practice regimens. From the real-time heart rate data retrieved, coaches can assess how much energy players expended, how hard their bodies were impacted and how much recovery time they will need to maximize performance on game day and throughout the season. The data collected is incredibly accurate and personalized based on each player's age, height, weight and fitness level.

    "The U.S. Soccer Federation recognizes the technological edge heart rate training provides," said Ivan Pierra, Head Trainer for the Men's National Team.  "This partnership with Polar ensures that each team is equipped with the most cutting edge technology to help us achieve our goals, while keeping our coaches and trainers informed and our players performing at their maximum potential."

    Players wear heart rate transmitters during training sessions and their heart rate information is transmitted wirelessly to a base station that can be viewed from the sidelines on a PC. This information is often used to guide the workouts and is automatically downloaded to the base station so that the data can also be reviewed later. With this information, U.S. Soccer trainers can ensure that each National Team player is game ready.

    "We are confident that the Polar technology and the Team2 Pro system will help us achieve higher levels of performance through detailed planning, measurement and analysis," said Pierra. "The system will also allow us to adequately gauge recovery time to ensure players are in peak shape for games and remain strong throughout the year, as well as help decrease the potential for injuries and avoid over-fatigue."

    For more information on Polar and its team offerings, please visit http://www.polarusa.com/us-en/b2b_products/team_sports.

    About Polar
    Headquartered in Lake Success, NY, Polar USA is a wholly-owned subsidiary of Finland-based Polar Electro OY, which invented the first wireless heart rate monitor (HRM) in 1977. Polar now operates internationally in more than 80 countries and its products are sold through 35,000 retailers globally. Polar heart rate and fitness assessment technology delivers unparalleled insight into the human body from valuable training guidance and feedback, to enabling individuals to improve their fitness level and sports performance. Polar technology is key to the success of leading fitness facilities, athletic teams, corporate wellness facilities, health insurance providers and thousands of physical education programs around the world. Today, Polar training computers are the number one choice among consumers worldwide. For more information, visit www.polarusa.com.

    The names of actual companies and products mentioned herein may be the trademarks of their respective owners.MEDIA Contacts:  

     Maria MartinezNeil BuetheCooperKatz for Polar USA

    U.S. Soccer Federation917-595-3059312-528-1270mmartinez@cooperkatz.comnbuethe@ussoccer.org


    '/>"/>
    SOURCE Polar
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Large Controlled Trial of Widely Used Mood Stabilizers Demonstrates Efficacy in Pediatric Bipolar Disorder
    2. Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder
    3. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
    4. Intra-Cellular Therapies Presents Data on Its Schizophrenia and Cognition in Schizophrenia Programs at the 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders
    5. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
    6. NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia, Bipolar Disorder and Depression
    7. Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder
    8. Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
    9. Alexzas AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial
    10. U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
    11. Study Suggests New Treatment Approach May be Needed for Management of Depression in Some People With Bipolar Disorder
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
    (Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
    (Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
    Breaking Medicine Technology:
    (Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
    (Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
    (Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
    (Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
    (Date:10/12/2017)... ... October 12, 2017 , ... HMP , a ... of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners ... October 11, 2017. , The annual award competition recognizes editorial and design excellence across ...
    Breaking Medicine News(10 mins):